Lantern Pharma (LTRN) Tops Q3 EPS by 14c

Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.42), $0.14 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Crude Inventory 0.4M Barrels Last Week - EIA
• Pediatric Oncology Group of Ontario (POGO) Opens the Market
• iShares 20+ Year Treasury Bond ETF (TLT) call put ratio 1 call to 1.7 puts on 754K contracts